Visceral Fat Research
Approved and investigational metabolic products compared by exact population, endpoint, and regulatory status.
ASK BETTER QUESTIONS
What changes a visceral fat research evidence decision?
- Was visceral fat measured directly?
- Does the population match the approved label?
- Is the product approved, investigational, or unapproved?
EVIDENCE RECORDS
Visceral Fat Research evidence records.
Tesamorelin
Tesamorelin has the strongest human evidence in a narrow, labeled population. Evidence from that population should not be generalized to routine weight management.
Open evidence recordSemaglutide
Semaglutide has a mature evidence base, but claims must remain tied to the specific product, indication, population, and label.
Open evidence recordTirzepatide
Tirzepatide is an approved dual-receptor medicine with a mature human evidence base; it is not interchangeable with investigational retatrutide.
Open evidence recordRetatrutide
Retatrutide has meaningful randomized human evidence, but it should not be described as an available approved alternative to semaglutide or tirzepatide.
Open evidence recordDIRECT COMPARISONS